A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. - Guimarães HP; de Barros E Silva PGM; Liporace IL; Sampaio RO; Tarasoutchi F; Paixão M; Hoffmann-Filho CR; Patriota R; Leiria TLL; Lamprea D; Precoma DB; Atik FA; et al. (American heart journal, 2021)